We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to show the MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
The latest versions of the Criminal Procedure Rules and of the Criminal Practice Directions made by the Lord Chief Justice.
Changes to Practice Direction 36L and 36M come into force on 30 December 2019.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Actions that trial sponsors should consider to build resilience into clinical trial design
How to approach sampling ambient air and the sampling and analytical techniques to use.
Keep up to date with the latest information from the UK GLP monitoring authority.
How to use a quasi-experimental study to evaluate your digital health product.
Helping public health practitioners conducting evaluations – choosing evaluation methods.
Guidance for clinical trials that use Decentralised Manufactured Investigational Medicinal Products (IMPs).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).